Analysis of Risk Factors for Revitrectomy in Eyes with Diabetic Vitreous Hemorrhage

References

• Tsiknakis N, Theodoropoulos D, Manikis G, et al. Deep learning for diabetic retinopathy detection and classification based on fundus images: a review. Comput Biol Med. 2021;135:104599. doi:10.1016/j.compbiomed.2021.104599
   PubMed Web of Science ®Google Scholar
• Yokota R, Inoue M, Itoh Y, Rii T, Hirota K, Hirakata A. Comparison of microincision vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy. Jpn J Ophthalmol. 2015;59(5):288–294. doi:10.1007/s10384-015-0396-y
   PubMed Web of Science ®Google Scholar
• Smith JM, Steel DH. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2015;2015(8):Cd008214. doi:10.1002/14651858.CD008214.pub3
   PubMed Web of Science ®Google Scholar
• Lee BJ, Yu HG. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy. Retina. 2010;30(10):1671–1677. doi:10.1097/IAE.0b013e3181dcfb79
   PubMed Web of Science ®Google Scholar
• Fujii GY, De Juan E, Humayun MS, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology. 2002;109(10):1814–1820. doi:10.1016/S0161-6420(02)01119-3
   PubMed Web of Science ®Google Scholar
• Khuthaila MK, Hsu J, Chiang A, et al. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2013;155(4):757–763. doi:10.1016/j.ajo.2012.11.004
   PubMed Web of Science ®Google Scholar
• Ding Y, Yao B, Hang H, Ye H. Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy. BMC Ophthalmol. 2020;20(1):292. doi:10.1186/s12886-020-01532-8
   PubMed Web of Science ®Google Scholar
• Brown GC, Tasman WS, Benson WE, McNamara JA, Eagle RC. Reoperation following diabetic vitrectomy. Arch Ophthalmol. 1992;110(4):506–510. doi:10.1001/archopht.1992.01080160084037
   PubMedGoogle Scholar
• Takayama K, Someya H, Yokoyama H, et al. Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study. Acta Ophthalmol. 2020;98(4):e434–e439. doi:10.1111/aos.14292
   PubMed Web of Science ®Google Scholar
• Al-Khersan H, Venincasa MJ, Kloosterboer A, et al. Pars plana vitrectomy reoperations for complications of proliferative diabetic retinopathy. Clin Ophthalmol. 2020;14:1559–1563. doi:10.2147/OPTH.S252285
   PubMed Web of Science ®Google Scholar
• Schreur V, Brouwers J, Van Huet RAC, et al. Long-term outcomes of vitrectomy for proliferative diabetic retinopathy. Acta Ophthalmol. 2021;99(1):83–89. doi:10.1111/aos.14482
   PubMed Web of Science ®Google Scholar
• Yan H, Cui J, Lu Y, Yu J, Chen S, Xu Y. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy. Curr Eye Res. 2010;35(4):308–313. doi:10.3109/02713680903572491
   PubMed Web of Science ®Google Scholar
• Gupta B, Wong R, Sivaprasad S, Williamson TH. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice. Eye. 2012;26(4):576–582. doi:10.1038/eye.2011.348
   PubMed Web of Science ®Google Scholar
• Nishi K, Nishitsuka K, Yamamoto T, Yamashita H. Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy. PLoS One. 2021;16(1):e0244281. doi:10.1371/journal.pone.0244281
   PubMed Web of Science ®Google Scholar
• Gündüz K, Bakri SJ. Management of proliferative diabetic retinopathy. Compr Ophthalmol Update. 2007;8(5):245–256.
   PubMedGoogle Scholar
• Lewis H, Abrams GW, Foos RY. Clinicopathologic findings in anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1987;104(6):614–618. doi:10.1016/0002-9394(87)90174-7
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Machida S, Fujiwara T, Ishibe T, Kurosaka D. Vitreous levels of vascular endothelial growth factor in eyes with anterior hyaloidal fibrovascular proliferation. Clin Ophthalmol. 2010;4:1043–1046. doi:10.2147/opth.s13193
   PubMedGoogle Scholar
• Lewis H, Abrams GW, Williams GA. Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1987;104(6):607–613. doi:10.1016/0002-9394(87)90173-5
   PubMed Web of Science ®Google Scholar
• Bhende M, Agraharam SG, Gopal L, et al. Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage. Ophthalmology. 2000;107(9):1729–1736. doi:10.1016/S0161-6420(00)00213-X
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Noma H, Mimura T, Sakata K, Hori S. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II. Br J Ophthalmol. 2004;88(8):1064–1068. doi:10.1136/bjo.2003.032656
   PubMed Web of Science ®Google Scholar
• Wakabayashi Y, Usui Y, Okunuki Y, et al. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012;53(10):6403–6410. doi:10.1167/iovs.12-10367
   PubMed Web of Science ®Google Scholar
• Song S, Yu X, Zhang P, Dai H. Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy. J Diabetes Complications. 2020;34(9):107641. doi:10.1016/j.jdiacomp.2020.107641
   PubMed Web of Science ®Google Scholar
• Ostri C, Lux A, Lund-Andersen H, la Cour M. Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study. Acta Ophthalmol. 2014;92(6):571–576. doi:10.1111/aos.12325
   PubMed Web of Science ®Google Scholar
• Poliner LS, Christianson DJ, Escoffery RF, Kolker AE, Gordon ME. Neovascular glaucoma after intracapsular and extracapsular cataract extraction in diabetic patients. Am J Ophthalmol. 1985;100(5):637–643. doi:10.1016/0002-9394(85)90617-8
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhang LD, Liu LF, et al. Blood levels of glycated hemoglobin, D-Dimer, and fibrinogen in diabetic retinopathy. Diabetes Metab Syndr Obes. 2021;14:2483–2488. doi:10.2147/DMSO.S309068
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao J, You Y, Li Z, Chen S. The ratio of fibrinogen to albumin is related to the occurrence of retinopathy in type 2 diabetic patients. Diabetes Metab Syndr Obes. 2023;16:1859–1867. doi:10.2147/DMSO.S407391
   PubMed Web of Science ®Google Scholar
• Huang Q, Wu H, Wo M, Ma J, Song Y, Fei X. Clinical and predictive significance of plasma fibrinogen concentrations combined monocyte-lymphocyte ratio in patients with diabetic retinopathy. Int J Med Sci. 2021;18(6):1390–1398. doi:10.7150/ijms.51533
   PubMed Web of Science ®Google Scholar
• Luyendyk JP, Schoenecker JG, Flick MJ. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood. 2019;133(6):511–520. doi:10.1182/blood-2018-07-818211
   PubMed Web of Science ®Google Scholar
• Sui J, Noubouossie DF, Gandotra S, Cao L. Elevated plasma fibrinogen is associated with excessive inflammation and disease severity in COVID-19 patients. Front Cell Infect Microbiol. 2021;11:734005. doi:10.3389/fcimb.2021.734005
   PubMed Web of Science ®Google Scholar
• Tomić M, Ljubić S, Kaštelan S, Gverović Antunica A, Jazbec A, Poljičanin T. Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm. 2013;2013:818671. doi:10.1155/2013/818671
   PubMed Web of Science ®Google Scholar
• Zhao XY, Xia S, Chen YX. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials. Br J Ophthalmol. 2018;102(8):1077–1085. doi:10.1136/bjophthalmol-2017-311344
   PubMed Web of Science ®Google Scholar
• Simunovic MP, Maberley DA. Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy: a systematic review and meta-analysis. Retina. 2015;35(10):1931–1942. doi:10.1097/IAE.0000000000000723
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. doi:10.1136/bmj.321.7258.405
   PubMed Web of Science ®Google Scholar
• Hirsch IB. glycemic variability and diabetes complications: does It matter? Of course it does! Diabetes Care. 2015;38(8):1610–1614. doi:10.2337/dc14-2898
   PubMed Web of Science ®Google Scholar
• Ceriello A, Kilpatrick ES. Glycemic variability: both sides of the story. Diabetes Care. 2013;36(Suppl 2):S272–275. doi:10.2337/dcS13-2030
   PubMedGoogle Scholar
• Hare MJ, Shaw JE, Zimmet PZ. Current controversies in the use of haemoglobin A1c. J Intern Med. 2012;271(3):227–236. doi:10.1111/j.1365-2796.2012.02513.x
   PubMed Web of Science ®Google Scholar
• Baget-Bernaldiz M, Romero-Aroca P, Mira-Puerto A, et al. Risk factors for recurrent vitreous hemorrhage in type 2 diabetes mellitus patients after posterior vitrectomy. J Clin Med. 2023;12(8):2989. doi:10.3390/jcm12082989
   PubMed Web of Science ®Google Scholar
• Sato T, Tsuboi K, Nakashima H, Emi K. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2017;255(4):665–671. doi:10.1007/s00417-016-3522-8
   PubMed Web of Science ®Google Scholar
• Zhao M, Chandra A, Xu J, Li J. Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients. BMC Ophthalmol. 2023;23(1):215. doi:10.1186/s12886-023-02940-2
   PubMed Web of Science ®Google Scholar
• Motoda S, Shiraki N, Ishihara T, et al. Predictors of postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy. J Diabetes Investig. 2018;9(4):940–945. doi:10.1111/jdi.12791
   PubMed Web of Science ®Google Scholar
• Tandias R, Lemire CA, Palvadi K, Arroyo JG. Posterior vitreous detachment status as a predictive factor for outcomes of vitrectomy for diabetic vitreous hemorrhage. Retina. 2022;42(6):1103–1110. doi:10.1097/IAE.0000000000003453
   PubMed Web of Science ®Google Scholar